肠道菌群
法尼甾体X受体
生物
G蛋白偶联胆汁酸受体
胆汁酸
脂质代谢
串扰
碳水化合物代谢
新陈代谢
微生物代谢
代谢途径
葡萄糖稳态
核受体
信号转导
生物化学
细胞生物学
胰岛素抵抗
糖尿病
细菌
内分泌学
转录因子
遗传学
基因
光学
物理
作者
Jin Jiang,Huange Zhang,Muhammad Hussain,Abdullah,Fengqin Feng,Rongfa Guan,Hao Zhong
出处
期刊:Biology
[Multidisciplinary Digital Publishing Institute]
日期:2025-07-02
卷期号:14 (7): 802-802
被引量:28
标识
DOI:10.3390/biology14070802
摘要
Metabolic dysregulation involving glucose and lipids is closely associated with chronic diseases such as type 2 diabetes mellitus. Emerging evidence highlights the regulatory role of bile acid (BA)-gut microbiota interactions in these metabolic disorders. The gut microbiota orchestrates the biotransformation of primary BAs into bioactive secondary BAs, which function as endocrine signaling molecules by activating the nuclear farnesoid X receptor (FXR) and G protein-coupled membrane receptor (TGR5), forming a communication network essential for metabolic homeostasis. BAs also reciprocally modulate gut microbiota composition. This BA-gut microbiota co-metabolism has emerged as a promising therapeutic target for lipid metabolism disorders. This comprehensive review examines the bidirectional interplay between gut microbiota and BA metabolism, focusing on microbial transformation of BAs, host-microbial co-regulatory pathways and mechanisms of BA metabolism, and the therapeutic implications of modulating the gut microbiota-BA axis in addressing glucose and lipid metabolism disorders. The synthesis of current evidence aims to elucidate the intricate crosstalk between microbial ecology and host metabolism mediated by BA signaling pathways, thereby exploring novel therapeutic intervention strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI